Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Molecular Formula
C28H36FN3O
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15254237 1 Vial
Lentiviral mouse Asxl3 shRNA (UAS) - Lentiviral mouse Asxl3 shRNA (UAS) (25)
Sign In for Pricing
View Details 
GTR15337627 1 Vial
Lentiviral human FERMT2 shRNA (UAS) - Lentiviral human FERMT2 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details